期刊文献+

慢病毒载体介导的基因转导技术对人脐血CD34^+细胞基因表达谱的影响 被引量:2

Influence of gene transduction mediated by lentivirus vector on gene expression of human CD34^+ cord blood cells
原文传递
导出
摘要 目的研究慢病毒载体(1entivirus vector)基因转导技术对脐血CD34^+细胞基因表达的影响。方法将携带绿色荧光蛋白(GFP)基因的第三代自身失活(self-inactivating,SIN)慢病毒载体导入CD34^+细胞。提取被病毒感染细胞的总RNA,应用cDNA微阵列技术对慢病毒载体感染的脐血CD34’细胞及正常对照细胞进行差异基因表达谱分析。结果在23000个被检测基因中,与无基因导入的对照组细胞比较,基因导入细胞中表达的上调基因共2个,分别为IGSF4和HEC基因,下调基因共6个,分别为HNRPA0、ZNF205、FLNA、CLK3、LDB1、ACTA1。进一步对筛选出的差异表达基因进行半定量RT-PCR分析证实基因表达水平变化不明显。结论本实验中应用的慢病毒载体对脐血CD34^+细胞基因表达无明显影响,有望成为临床基因治疗有效且安全的工具。 Objective To investigate the influence of gene transduction mediated by lentivims vector on haman CD34^+ cord blood cell (CBCs) gene expression. Methods CD34^+ cells were isolated and trans- duced with the third-generation self-inactivating (SIN) lentiviral vector carrying green fluorescent protein (GFP). The total RNA from transduced cells was extracted and the differences of genotypes between the transduced and non-transduced CD34^+ cells were determined with cDNA microarray analysis . Results In 23000 genes two were upregulated and six downregulated. These changes were not confirmed by semi-quanti-tative RT-PCR method. Conclusions Lentiviral vector used in this study do not influence significantly on the gene expression of CD34^+ CBCs, and the vector system may be a useful and safe one in clinical gene therapy.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2008年第6期393-396,共4页 Chinese Journal of Hematology
基金 基金项目:国家自然科学基金(30672425)
关键词 慢病毒载体 胎血 造血干细胞 基因疗法 Lentivirus vector Cord blood Hematopoietic stem cell Gene therapy
  • 相关文献

参考文献16

  • 1Soda Y, Tani K, Bai Y, et al. A novel Maxizyme vector targeting a bcr-abl fusion gent induced specific cell death in Philadelphia chromosome-positive lymphoblastic acute leukemia. Blood, 2004, 104 : 356-363.
  • 2Bai Y, Soda Y, Izawa K, et al. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector. Gene Ther, 2003, 10: 1446-1457.
  • 3Ono K, Tanaka T, Tsunoda T, et al. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res, 2000, 60 : 5007-5011.
  • 4Segall H, Sutton RE. Detection of replication-competent lentiviral particles. Methods Mol Biol, 2003, 229: 87-94.
  • 5Escarpe P, Zayek N, Chin P, et al. Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations. Mol Ther, 2003, 8: 332-341.
  • 6Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 2003, 302: 415-419.
  • 7Manilla P, Rebello T, Afable C, et al. Regulatory considerations for novel gene therapy products : a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther, 2005, 16: 17- 25.
  • 8Schonely K, Afable C, Slepushkin V, et al. QC release testing of an HIV-1 based lentiviral vector lot and transduced cellular product. Bioprocess J, 2003, 2: 39-47.
  • 9Kuramochi M, Fukuhara H, Nobukuni T, et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat genet, 2001, 27: 427-430.
  • 10Lin YT, Chen Y, Wu G, et al. Hecl sequentially recruits Zwint- 1 and ZW10 to kinetochores for faithful chromosome segregation and spindle checkpoint control. Oncogene, 2006, 25: 6901- 6914.

同被引文献13

  • 1Bai Y, Soda Y, Izawa K, et al. Effective transduetion and stable transgene expression in human blood cells by a thirdgenerationlentivlral vector[J] GeneTher, 2003, 10 (17): 1446-1457.
  • 2Schmidt M, Glimm H, Wissler M, et al. Efficient characterization of retro-, lenti , and foamyveetor transduced ceil populations by high-accuracy insertion site sequencing [J]. Ann N Y Acad Sci, 2003, 996 (5): 112-121.
  • 3Soda Y, Tani K, Bai Y, et al. A novel Maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome positive lymphoblastie acute leukemia [J]. Blood, 2004, 104 (2):356-363.
  • 4Chang AH, Sadelain M. The genetic engineering of hematopoietic stem cells: the rise of lentiviral vectors, the conundrum of the hr, and the promise of lineage-restricted vectors [J]. MolTher, 2007, 15 (3): 445-56.
  • 5Lech P, Somia NV. Retrovirus vectors [J]. Contrib Nephrol, 2008, 159 (1):30-46.
  • 6Lim KI, Schaffer DV. Library selection approaches to engineering enhanced retroviral and lentiviral vectors [J]. CombChem High Throughput Screen, 2008, 11 (2): 111- 117.
  • 7Neschadim A, McCart JA, Keating A, et al. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation [ J ]. Biol Blood Marrow Transplant, 2007, 13 (12): 1407-1416.
  • 8Cockrell AS, Kafri T. Gene delivery by lentivirus vectors [J]. Mol Biotechnol, 2007, 36 (3): 184-204.
  • 9Bai Y,Soda Y,Izawa K,et al.Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector[J].Gene Ther,2003,10:1446.
  • 10Schmidt M,Glimm H,Wissler M,et al.Efficient characterization of retro-,lenti-,and foamyvector-transduced cell populations by high-accuracy insertion site sequencing[J].Ann.N.Y.Acad.Sci,2003,996:112.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部